Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Gerhard Ries | M | 55 |
Lumavita AG
 Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | - |
| Cees Winnips | M | - |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | 6 ans |
| Markus Brand | M | - |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | 6 ans |
| Michael Tintiuc | M | - |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | 6 ans |
| Leonz Meyer | M | - |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | 6 ans |
| Manfred Schulz | M | - |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | 6 ans |
| Jürg Eckhardt | M | - |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | - |
| Olivier Valdenaire | M | - |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | - |
| Gunnar Magnus Modee Persson | M | 64 |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | - |
| Regina Hodits | M | 53 |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | - |
| Nicholas Benedict | M | - |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | - |
| Ankit Mahadevia | M | 43 |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | 6 ans |
| Roland Grimm | M | - |
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | 5 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Suisse | 13 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Omar Lahlou
- Réseau Personnel
